Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Inflammatory Bowel Diseases
|
December 25, 2008
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
Jeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 20, 2012
Budesonide use in pediatric Crohn disease
Anthony Otley, Neal LeLeiko, Christine Langton, et al.
Frontiers in Oncology
|
August 2, 2021
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies
Nivedita M Ratnam, Heather M Sonnemann, Stephen C Frederico, et al.
The American Journal of Gastroenterology
|
January 28, 2010
Outcome following infliximab therapy in children with ulcerative colitis
Jeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 10, 2021
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab
Rajat Banerjee, Min Liu, Emily Bellile, et al.
Neuro-Oncology
|
January 3, 2018
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma
Shuyu Hao, Hua Song, Wei Zhang, et al.
Inflammatory Bowel Diseases
|
January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)
Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases
|
November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease
David J Keljo, James Markowitz, Christine Langton, et al.
The American Journal of Gastroenterology
|
January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study
Jeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease
Victoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Inflammatory Bowel Diseases
|
December 25, 2008
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
Jeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 20, 2012
Budesonide use in pediatric Crohn disease
Anthony Otley, Neal LeLeiko, Christine Langton, et al.
Frontiers in Oncology
|
August 2, 2021
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies
Nivedita M Ratnam, Heather M Sonnemann, Stephen C Frederico, et al.
The American Journal of Gastroenterology
|
January 28, 2010
Outcome following infliximab therapy in children with ulcerative colitis
Jeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 10, 2021
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab
Rajat Banerjee, Min Liu, Emily Bellile, et al.
Neuro-Oncology
|
January 3, 2018
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma
Shuyu Hao, Hua Song, Wei Zhang, et al.
Inflammatory Bowel Diseases
|
January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)
Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases
|
November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease
David J Keljo, James Markowitz, Christine Langton, et al.
The American Journal of Gastroenterology
|
January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study
Jeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease
Victoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Page
of 6